1026757

Apozeal Pharmaceuticals Inc. — FEI 3004536846

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 5, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Levittown, PA (United States)